JP2023528416A5 - - Google Patents

Info

Publication number
JP2023528416A5
JP2023528416A5 JP2022574199A JP2022574199A JP2023528416A5 JP 2023528416 A5 JP2023528416 A5 JP 2023528416A5 JP 2022574199 A JP2022574199 A JP 2022574199A JP 2022574199 A JP2022574199 A JP 2022574199A JP 2023528416 A5 JP2023528416 A5 JP 2023528416A5
Authority
JP
Japan
Application number
JP2022574199A
Other languages
Japanese (ja)
Other versions
JP2023528416A (ja
JP7767322B2 (ja
JPWO2021247426A5 (https=
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2021/034947 external-priority patent/WO2021247426A1/en
Publication of JP2023528416A publication Critical patent/JP2023528416A/ja
Publication of JP2023528416A5 publication Critical patent/JP2023528416A5/ja
Publication of JPWO2021247426A5 publication Critical patent/JPWO2021247426A5/ja
Priority to JP2025182305A priority Critical patent/JP2026053316A/ja
Application granted granted Critical
Publication of JP7767322B2 publication Critical patent/JP7767322B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2022574199A 2020-06-04 2021-05-28 抗abcg2抗体及びそれらの使用 Active JP7767322B2 (ja)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP2025182305A JP2026053316A (ja) 2020-06-04 2025-10-29 抗abcg2抗体及びそれらの使用

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US202063034806P 2020-06-04 2020-06-04
US63/034,806 2020-06-04
PCT/US2021/034947 WO2021247426A1 (en) 2020-06-04 2021-05-28 Anti-abcg2 antibodies and uses thereof

Related Child Applications (1)

Application Number Title Priority Date Filing Date
JP2025182305A Division JP2026053316A (ja) 2020-06-04 2025-10-29 抗abcg2抗体及びそれらの使用

Publications (4)

Publication Number Publication Date
JP2023528416A JP2023528416A (ja) 2023-07-04
JP2023528416A5 true JP2023528416A5 (https=) 2024-06-04
JPWO2021247426A5 JPWO2021247426A5 (https=) 2024-06-04
JP7767322B2 JP7767322B2 (ja) 2025-11-11

Family

ID=76601796

Family Applications (2)

Application Number Title Priority Date Filing Date
JP2022574199A Active JP7767322B2 (ja) 2020-06-04 2021-05-28 抗abcg2抗体及びそれらの使用
JP2025182305A Pending JP2026053316A (ja) 2020-06-04 2025-10-29 抗abcg2抗体及びそれらの使用

Family Applications After (1)

Application Number Title Priority Date Filing Date
JP2025182305A Pending JP2026053316A (ja) 2020-06-04 2025-10-29 抗abcg2抗体及びそれらの使用

Country Status (7)

Country Link
US (1) US20230212305A1 (https=)
EP (1) EP4161650A1 (https=)
JP (2) JP7767322B2 (https=)
CN (1) CN116323662A (https=)
AU (1) AU2021284240A1 (https=)
CA (1) CA3182472A1 (https=)
WO (1) WO2021247426A1 (https=)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2023159220A1 (en) 2022-02-18 2023-08-24 Kenjockety Biotechnology, Inc. Anti-cd47 antibodies
WO2025222167A1 (en) * 2024-04-19 2025-10-23 Zb17 Llc Methods of treatment
WO2025222168A1 (en) * 2024-04-19 2025-10-23 Zb17 Llc Methods of treatment
WO2025222170A1 (en) * 2024-04-19 2025-10-23 Zb17 Llc Methods of treatment

Family Cites Families (33)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3920358A1 (de) 1989-06-22 1991-01-17 Behringwerke Ag Bispezifische und oligospezifische, mono- und oligovalente antikoerperkonstrukte, ihre herstellung und verwendung
EP0557300B1 (en) 1990-10-29 1997-11-19 Chiron Corporation Bispecific antibodies, method of production, and uses thereof
TW197439B (https=) 1991-04-04 1993-01-01 Ueno Pharmaceutics Applic Res Co Ltd
US5283253A (en) 1991-09-23 1994-02-01 Florida State University Furyl or thienyl carbonyl substituted taxanes and pharmaceutical compositions containing them
WO1993010076A1 (en) 1991-11-22 1993-05-27 The University Of Mississippi Synthesis and optical resolution of the taxol side chain and related compounds
DE69232137T2 (de) 1991-11-25 2002-05-29 Enzon Inc Multivalente antigen-bindende proteine
US5200534A (en) 1992-03-13 1993-04-06 University Of Florida Process for the preparation of taxol and 10-deacetyltaxol
JPH08500973A (ja) 1992-05-21 1996-02-06 ザ ペン ステイト リサーチ ファウンデーション タキソール、関連タキサン及び他の新規な抗癌/抗ウイルス性化合物原料としてのイチイ培養組織
US5274137A (en) 1992-06-23 1993-12-28 Nicolaou K C Intermediates for preparation of taxols
US5294637A (en) 1992-07-01 1994-03-15 Bristol-Myers Squibb Company Fluoro taxols
US5202448A (en) 1992-08-14 1993-04-13 Napro Biotherapeutics, Inc. Processes of converting taxanes into baccatin III
CA2100808A1 (en) 1992-10-01 1994-04-02 Vittorio Farina Deoxy paclitaxels
FR2696463B1 (fr) 1992-10-05 1994-11-25 Rhone Poulenc Rorer Sa Procédé d'obtention de la désacétyl-10 baccatine III.
FR2696458B1 (fr) 1992-10-05 1994-11-10 Rhone Poulenc Rorer Sa Procédé de préparation de dérivés du taxane.
FR2696464B1 (fr) 1992-10-05 1994-11-10 Rhone Poulenc Rorer Sa Nouveau procédé d'estérification de la baccatine III et de la désacétyl-10 baccatine III.
FR2696462B1 (fr) 1992-10-05 1994-11-25 Rhone Poulenc Rorer Sa Procédé d'obtention de la désacétyl-10 baccatine III.
FR2696461B1 (fr) 1992-10-05 1994-11-10 Rhone Poulenc Rorer Sa Nouveaux dérivés d'analogues du taxol, leur préparation et les compositions qui les contiennent.
US6063621A (en) * 1992-10-27 2000-05-16 Queen's University At Kingston Antibodies to a multidrug resistance protein
US5279949A (en) 1992-12-07 1994-01-18 Board Of Trustees Operating Michigan State University Process for the isolation and purification of taxol and taxanes from Taxus spp
US5824701A (en) 1993-10-20 1998-10-20 Enzon, Inc. Taxane-based prodrugs
US5415869A (en) 1993-11-12 1995-05-16 The Research Foundation Of State University Of New York Taxol formulation
WO1998008833A1 (en) 1996-08-26 1998-03-05 Bristol-Myers Squibb Company Sulfenamide taxane derivatives
EP0961619A4 (en) 1996-09-27 2001-09-26 Bristol Myers Squibb Co HYDROLYSABLE DRUGS FOR THE RELEASE OF ANTI-CANCER DRUGS IN METASTATIC CELLS
AU4966597A (en) 1996-11-19 1998-06-10 Daiichi Pharmaceutical Co., Ltd. Taxol derivatives
US5977386A (en) 1996-12-24 1999-11-02 Bristol-Myers Squibb Company 6-thio-substituted paclitaxels
IL133585A0 (en) 1997-06-20 2001-04-30 Baker Norton Pharma Soluble prodrugs of paclitaxel
US7288665B1 (en) 1997-08-18 2007-10-30 Florida State University Process for selective derivatization of taxanes
JPH1192468A (ja) 1997-09-17 1999-04-06 Yakult Honsha Co Ltd 新規なタキサン誘導体
WO1999018113A1 (fr) 1997-10-08 1999-04-15 Bio Research Corporation Of Yokohama Derives taxoides et leur procede de production
WO2003035685A1 (en) * 2001-10-24 2003-05-01 Solvo Biotechnology Inc. Use of a half-transporter protein of the abcg-family for selecting cells and in gene therapy
EP3023437A1 (en) * 2014-11-20 2016-05-25 EngMab AG Bispecific antibodies against CD3epsilon and BCMA
CN110655582B (zh) * 2015-01-08 2022-12-16 江苏康宁杰瑞生物制药有限公司 具有共同轻链的双特异性抗体或抗体混合物
CN106432490B (zh) * 2016-09-14 2020-01-07 北京大学 一种abcg2单克隆抗体及其用途

Similar Documents

Publication Publication Date Title
JP2023528416A5 (https=)
CN305674525S (https=)
CN305718797S (https=)
CN305533562S (https=)
CN305532078S (https=)
CN305531449S (https=)
CN305530385S (https=)
CN305530214S (https=)
CN305533636S (https=)
CN305528942S (https=)
CN305527127S (https=)
CN305867239S (https=)
CN305865999S (https=)
CN305857630S (https=)
CN305825327S (https=)
CN305672589S (https=)
CN305821570S (https=)
CN305811429S (https=)
CN305665517S (https=)
CN305747827S (https=)
CN305746792S (https=)
CN305664673S (https=)
CN305743149S (https=)
CN305727601S (https=)
CN305727377S (https=)